Latest Positron Stories

CHICAGO, May 3, 2013 /PRNewswire/ -- Positron Corporation (OTCBB: POSC), a nuclear medicine healthcare company specializing in the field of cardiac Positron Emission Tomography (PET) imaging and high tech pharmacy automation, today announced a co-marketing agreement with Biologics Modular. Biologics Modular designs and manufacturers modular facilities that serve as self-contained biorepositories, biomanufacturing suites and research suites. "As we look to accelerate PosiRx®...

John P. Millis, Ph.D. for redOrbit.com – Your Universe Online All fundamental matter in the Universe – protons, electrons, etc. – has counterparts known as antimatter. In most ways, antimatter simply mirrors regular matter. For instance, the antimatter counterpart to the electron is the positron, a particle of the same mass of the electron, but possessing the opposite charge and opposite spin. When normal matter encounters its antimatter counterpart, the pair will annihilate and...

[ Watch the Video: AMS Time Lapse Installation ] John P. Millis, Ph.D. for redOrbit.com – Your Universe Online For decades scientists have wondered whether a mysterious form of matter – known simply as Dark Matter since it does not interact directly with light – makes up the majority of the “stuff” in the Universe. Researchers have pointed to the seminal work on the Bullet Cluster of galaxies as evidence that dark matter is a real substance. But similar observations of...

redOrbit Staff & Wire Reports - Your Universe Online By aiming a laser at antihydrogen atoms, researchers have found that they can force them to lose energy and plummet to temperatures 25-times colder than previously achieved -- a discovery which could greatly assist the study of the more elusive properties of antimatter. The method, which was developed by a team of experts from the US and Canada, is described in the most recent edition of the Journal of Physics B: Atomic, Molecular...

CHICAGO, Dec. 7, 2012 /PRNewswire/ -- Positron Corporation (OTCBB: POSC) posts their first commercial sale and shipment of Active Pharmaceutical Ingredient (API) grade Strontium-82 to a North American pharmaceutical company. Manhattan Isotope Technology (MIT), LLC, a wholly owned subsidiary of Position Corporation, completed the processing, production and shipment of their API grade strontium-82, which was delivered this week. The API was produced from target material received from...

CHICAGO, Nov. 15, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a nuclear medicine healthcare company, announced today the appointment of Charles Conroy as Chief Operating Officer. Conroy's background includes extensive experience in corporate & product strategy, partner & alliance management, licensing, acquisitions, divestitures and portfolio management. During his career, Conroy has led highly successful global business development, marketing, and operations...

CHICAGO, Oct. 16, 2012 /PRNewswire/ -- Positron Corporation announced today that the United States Patent and Trademark Office (USPTO) has awarded the Company a patent (U.S. No. 8,269,181) for its original semiconductor detector used in high precision measuring of coordinates and detection of ionization particles. The technology and patent issuance was achieved through collaboration with Dr. Valeri Saveliev of DESY in Hamburg, Germany. Dr. Saveliev's expertise in avalanche pixel...

LUBBOCK, Texas, Aug. 7, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC) a leading molecular imaging healthcare company is pleased to announce the consolidation and integration of operations at the Crown Point, Indiana facility to its Lubbock, Texas site. With the acquisition of Manhattan Isotope Technology (MIT), Positron gained the expertise, knowledge and radioactive materials facilities to manage all of the Company's radiopharmaceutical and radioisotope development,...

GARY, Ind., July 20, 2012 /PRNewswire/ -- Positron Corporation (OTCBB:POSC), a leading molecular imaging healthcare company, announces approval of a Pledge Resolution for $15 Million in Tax Increment Financing (TIF) Bonds, from the Redevelopment Commission of the City of Gary, Indiana towards the development of Positron's 70 MeV cyclotron project. In addition to the TIF incentives, the City of Gary will assist in sourcing the appropriate allocation of New Market Tax Credits (NMTC)...

LUBBOCK, Texas, June 5, 2012 /PRNewswire/ -- Positron Corporation a leading molecular imaging healthcare company, specializing in the field of nuclear cardiology announces completion of its first strontium validation effort. In May 2012, Manhattan Isotope Technology (MIT), a Positron subsidiary, successfully processed strontium. The internal analysis of the product demonstrates it meets the Sr-82 purity specifications required for the formulation of Sr-82/Rb-82 generators. MIT has now...